Clinical Outcomes of Switching U-100 Intermediate or Basal Insulin to U-200 Insulin Degludec or U-300 Insulin Glargine. [PDF]
Rosario N +8 more
europepmc +1 more source
C. Wysham +7 more
semanticscholar +1 more source
Budget impact analysis of insulin glargine vs. isophane protamine insulin treatment for patients with type-2 diabetes and severe hypoglycemia in Thailand. [PDF]
Permsuwan U, Deerochanawong C.
europepmc +1 more source
How do you convert a patient from insulin glargine to 70/30 NovoLog?
Tripdatabase
openalex +1 more source
Analysis of patient characteristics and safety of insulin glargine U300 use in 21 359 patients with type-2 diabetes and chronic kidney disease: DPV registry study. [PDF]
Vijayan A +9 more
europepmc +1 more source
An exploratory analysis of the cost-effectiveness of insulin glargine 300 units/mL versus insulin glargine 100 units/mL over a lifetime horizon using the BRAVO diabetes model. [PDF]
Shao H +5 more
europepmc +1 more source
Insulin Access Enhancement in India: Expert Views on Integrating Interchangeable Biosimilar Insulin Glargine. [PDF]
Prasanna Kumar KM +11 more
europepmc +1 more source
Clinically meaningful improvements in treatment satisfaction in insulin-naïve people with type 2 diabetes post initiation of insulin glargine 300 U/mL: A post hoc analysis of real-world ATOS study. [PDF]
Snoek F +11 more
europepmc +1 more source
Wendy Lane +7 more
semanticscholar +1 more source

